| Symbol | BIESF |
|---|---|
| Name | BIOTEST GMBH & CO KGAA |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 63303 Germany Landsteinerstrasse 5 |
| Telephone | +49 6103 801 4406 |
| Fax | — |
| — | |
| Website | https://www.biotest.com/de/en/index.cfm |
| Incorporation | DE |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Borse Hamburg |
| CIK | 0001485561 |
| Description | Biotest is a provider of biological therapeutics derived from human plasma. The Companys products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. For patients with serious and often chronic diseases they provide targeted treatment, which generally enable them to lead almost normal lives. Additional info from OTC: |
No news found.